Skip to main content
62°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NVS
Recent news which mentions NVS
< Previous
1
2
3
4
5
6
7
8
9
...
25
26
Next >
Novartis To Buy US Kidney Drug Developer Regulus Therapeutics For Around $800 Million
Today 11:22 EDT
Tickers
NEWS
NVS
RGLS
Tags
News
Large Cap
Market News
From
Benzinga
Novartis Q1 Earnings Beat Street View, CEO 'Confident' In Delivering Upgraded Guidance
April 29, 2025
Tickers
NEWS
NVS
Tags
Briefs
General
Market News
From
Benzinga
US Stock Futures Edge Higher Tuesday: Expert Warns Of 'Perfect Volatility Storm' With Major Earnings And Economic Data Due This Week
April 29, 2025
Tickers
AAPL
ABBV
AMZN
AON
Tags
Markets
S&P 500
Economics
From
Benzinga
General Motors, Coca-Cola And 3 Stocks To Watch Heading Into Tuesday
April 29, 2025
Tickers
GM
KO
NEWS
NVS
Tags
SBUX
SANM
News
From
Benzinga
Earnings Scheduled For April 29, 2025
April 29, 2025
Tickers
AAT
ABG
ACGL
AEYE
Tags
SFD
FCF
ASTL
From
Benzinga
Earnings Preview For Novartis
April 28, 2025
Tickers
NVS
Tags
Market News
BZI/EP
Benzinga
From
Benzinga
These 2 Top Dividend Stocks Are Making Moves to Avoid the Impact of Tariffs: Are They Buys?
April 26, 2025
Tickers
JNJ
NVS
Tags
NVS
JNJ
Recent Press Releases
From
Motley Fool
Roche Plans $50 Billion US Investment Over 5 Years With 12,000 New Jobs
April 22, 2025
Tickers
JNJ
LLY
NEWS
NVS
Tags
LLY
News
Top Stories
From
Benzinga
S&P 500, Nasdaq Futures Rise After Stocks Dip Amid Trump's Jabs At Powell, Strong Yen Gives Nikkei A Volatile Start
April 21, 2025
Tickers
LMT
NVS
SAP
TSLA
Tags
Donald Trump
NVS
SAP
From
Benzinga
2 Dividend Stocks Defying the Tariff-Fueled Market Correction to Buy and Hold Forever
April 17, 2025
Tickers
AMGN
AZN
NVS
Tags
AZN
Market News
Recent Press Releases
From
Motley Fool
Novartis Commits $23 Billion To Expand US Manufacturing Over Five Years, Despite Tariffs Uncertainties
April 11, 2025
Tickers
JNJ
LLY
NEWS
NVS
Tags
News
LLY
Large Cap
From
Benzinga
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline
April 09, 2025
Tickers
ARGX
AZN
GILD
GSK
Tags
NVS
RHHBY
Government
From
Benzinga
Cell Therapy Maker Legend Biotech Is An 'Attractive Opportunity' Due To No Material Tariff Exposure: Analyst
April 08, 2025
Tickers
JNJ
LEGN
NEWS
NVS
Tags
Price Target
General
Briefs
From
Benzinga
3 Health Care Stocks Whale Activity In Today's Session
April 08, 2025
Tickers
CVS
NVS
TLRY
Tags
CVS
BZI/AUOA
TLRY
From
Benzinga
Novartis Secures Third FDA Approval For Its Kidney Disease Portfolio In One Year
April 03, 2025
Tickers
NEWS
NVS
Tags
Health Care
Stories That Matter
Benzinga
From
Benzinga
FDA Reviews Kidney Disease Drug From Apellis Pharmaceuticals
April 01, 2025
Tickers
APLS
NEWS
NVS
Tags
News
Analyst Color
Expert Ideas
From
Benzinga
FDA OKs Novartis Prostate Cancer Treatment, Triples Eligible Patient Pool
March 28, 2025
Tickers
NEWS
NVS
Tags
FDA
Benzinga
Large Cap
From
Benzinga
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
March 21, 2025
Tickers
AMGN
AZN
BIIB
BMY
Tags
NVS
RHHBY
Biotech
From
Benzinga
FDA Approves Expanded Use Of Novartis Rare Disease Drug As Only Treatment For Rare Type Of Kidney Disease
March 21, 2025
Tickers
NEWS
NVS
Tags
Benzinga
FDA
Stories That Matter
From
Benzinga
Novartis Partner Monte Rosa Therapeutics Touts Positive Data From Early-Stage Study Of Investigational Drug Candidate For Immune-Mediated Disorders
March 20, 2025
Tickers
GLUE
NEWS
NVS
Tags
News
NVS
GLUE
From
Benzinga
Novartis New Data From Single-Dose Gene Therapy Shows Meaningful Efficacy, Safety In Patients With Spinal Muscular Atrophy
March 19, 2025
Tickers
BIIB
NEWS
NVS
RHHBY
Tags
NVS
RHHBY
Biotech
From
Benzinga
The Best Vanguard ETF to Invest $1,000 in Right Now
March 18, 2025
Tickers
NSRGY
NVS
RHHBY
SAP
Tags
SONY
Market News
NVS
From
Motley Fool
These 2 Vanguard ETFs Are Crushing the S&P 500 in 2025. Should You Buy?
March 11, 2025
Tickers
CBA
HSBC
HTHIY
MUFG
Tags
Recent Press Releases
VIGI
VYMI
From
Motley Fool
Teladoc Health Partners With Eli Liily's LillyDirect to Expand Access to Zepbound For Weight Loss
March 06, 2025
Tickers
LLY
NEWS
NVS
TDOC
Tags
Top Stories
LLY
TDOC
From
Benzinga
Roche Touts Food Allergy Drug As Superior Than Oral Immunotherapy
March 03, 2025
Tickers
NEWS
NVS
RHHBY
Tags
Health Care
Benzinga
pharmaceuticals
From
Benzinga
3 Dividend Stocks That Are No-Brainer Buys Right Now
March 01, 2025
Tickers
JNJ
NVS
PFE
Tags
NVS
PFE
JNJ
From
Motley Fool
Court Dismisses Novartis Challenge To Medicare Drug Price Negotiation Program
February 26, 2025
Tickers
NEWS
NVS
Tags
Government
Biotech
NVS
From
Benzinga
Is the Market Bullish or Bearish on Novartis?
February 26, 2025
Tickers
NVS
Tags
Short Ideas
Market News
Trading Ideas
From
Benzinga
NHS England's Transition From Biogen's Drug To Sandoz's Biosimilar Sparks Alarm As Multiple Sclerosis Patients Report Severe Effects
February 24, 2025
Tickers
BIIB
NEWS
NVS
SDZNY
Tags
Benzinga
Stories That Matter
Health Care
From
Benzinga
This Kraft Heinz Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday
February 13, 2025
Tickers
ASPN
KHC
NEWS
NVS
Tags
Trading Ideas
Benzinga
Markets
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
25
26
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.